ADVANCED TECHNOLOGIES FOR COMBAT CASUALTY CARE (CCC) RFI

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DEF ADVANCED RESEARCH PROJECTS AGCY

Contract Value

Not provided

Codes & Classification
Solicitation Number

DARPA-SN-26-06

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Classification Code

AC12

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents2
The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has issued a Special Notice (Procurement Identifier: DARPA-SN-26-06) titled "Advanced Technologies for Combat Casualty Care (CCC) RFI." This Request for Information (RFI) seeks input from a broad spectrum of stakeholders—including industry, academic institutions, government laboratories, and non-traditional performers—regarding cutting-edge medical technologies that have the potential to revolutionize the continuum of care for combat casualties, particularly in contested and resource-constrained environments. The primary purpose of this RFI is to gather information and insights on the latest advancements in medical sensing, computational modeling, actuation, therapeutics, and robotics. DARPA is interested in technologies that could significantly enhance the ability to deliver effective medical care in challenging operational settings, where resources may be limited and conditions are unpredictable. The scope of the RFI encompasses a wide array of technological domains, with a focus on solutions that can transform casualty care from point of injury through evacuation and treatment. Key objectives of this information-gathering activity include identifying innovative approaches, emerging capabilities, and potential gaps in current technologies that could inform future research and development efforts. Respondents are encouraged to share details about advanced systems, methodologies, and platforms that address the unique challenges of combat casualty care, with an emphasis on integration, scalability, and operational effectiveness. The contracting entity for this RFI is the Defense Advanced Research Projects Agency (DARPA), a federal office recognized for its leadership in pioneering research and development initiatives. The relevant classification for this opportunity is NAICS Code 541714, which pertains to Research and Development in Biotechnology (except Nanobiotechnology), and Product Service Code AC12, indicating a focus on R&D in the life sciences sector. This RFI is issued solely for planning and information-gathering purposes; it does not constitute a solicitation for proposals, abstracts, or quotations, and no contract will be awarded as a result of responses to this notice. There are no set-aside requirements or special considerations specified, and the notice is currently marked as inactive. Interested parties are invited to direct their responses and inquiries to Dr. Roozbeh Jafari at DARPA/BTO via the provided email address: [email protected]. Additional details, including attachments related to the notice, can be accessed through the official SAM.gov opportunity page at https://sam.gov/opp/faacd86edb594b09b00e3ae74fd8fd18/view. Contractors evaluating this opportunity should note that the RFI is intended to inform DARPA’s future program planning and does not represent a commitment to procure any specific technology or service. The focus remains on gathering comprehensive information about advanced biotechnology solutions that can address the enduring needs of combat casualty care in complex operational environments.